Triglav Skladi’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Triglav Skladi's EW Position: Q3 2026 in Review
Triglav Skladi held its Edwards Lifesciences (EW) position steady in Q3 2026 at 18,060 shares worth $1.56M. The position accounts for 0.08% of the portfolio, ranked #124.
Triglav Skladi first reported a position in EW in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.63M in Q2 2026. 1,344 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Triglav Skladi held 18,060 shares of Edwards Lifesciences worth $1.56M as of Q3 2026.
- Triglav Skladi left its Edwards Lifesciences share count unchanged in Q3 2026.
- Edwards Lifesciences made up 0.08% of Triglav Skladi's portfolio in Q3 2026, its #124 holding.
- Triglav Skladi first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 8 quarters since.
- Triglav Skladi's Edwards Lifesciences position peaked at $1.63M in Q2 2026.
- 1,344 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Triglav Skladi's 13F filing for Q3 2026, filed 6 Nov 2026.